08:00 , Jan 26, 2009 |  BC Week In Review  |  Company News

Ipsogen sales and marketing update

Ipsogen S.A. (Euronext:ALIPS), Marseille, France   Business: Diagnostic   Ipsogen launched three molecular diagnostic kits for leukemia in 4Q08: FusionQuant BCR-ABL IVD to detect and monitor chronic myelogenous leukemia (CML); ProfileQuant CLLU1 to measure the...